Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Ora H. Pescovitz | Director | 2025-04-08 | 7,693 | $5.89 | $45.31kBuy |
Carl L. Gordon | Director | 2025-02-18 | 94,100 | $10.84 | $1.02MBuy |
Orbimed Advisors LLC | Director | 2025-02-18 | 49,070 | $10.84 | $531.92kBuy |
Orbimed Advisors LLC | Director | 2025-02-18 | 94,100 | $10.84 | $1.02MBuy |
Carl L. Gordon | Director | 2025-02-18 | 49,070 | $10.84 | $531.92kBuy |
Carl L. Gordon | Director | 2025-02-14 | 17,962 | $9.90 | $177.82kBuy |
Orbimed Advisors LLC | Director | 2025-02-14 | 17,962 | $9.90 | $177.82kBuy |
Orbimed Advisors LLC | Director | 2025-02-14 | 29,540 | $9.85 | $290.97kBuy |
Carl L. Gordon | Director | 2025-02-14 | 29,540 | $9.85 | $290.97kBuy |
P. Kent Hawryluk | President CEO | 2025-02-04 | 50,000 | $10.69 | $534.50kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Frazier Life Sciences Management LP | 17.91% | 5,985,347 | $44.95M | Institution |
Orbimed Advisors LLC | 13.64% | 4,560,102 | $34.25M | Insider |
Carl L. Gordon | 13.64% | 4,560,102 | $34.25M | Insider |
Patrick J. Heron | 13.62% | 4,552,774 | $34.19M | Insider |
Frazier Life Sciences X LP | 13.62% | 4,552,774 | $34.19M | Insider |
Orbimed Advisors LLC | 11.41% | 3,812,215 | $28.63M | Institution |
Nea Management Company LLC | 10.81% | 3,614,486 | $27.14M | Institution |
Scott D. Sandell | 10.81% | 3,614,486 | $27.14M | Insider |
Paul Edward Walker | 10.81% | 3,614,486 | $27.14M | Insider |
Carmen Chang | 10.81% | 3,614,486 | $27.14M | Insider |